Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Clinical and Experimental Reproductive Medicine

2002 (v1, n1) to Present ISSN: 1671-8925

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

615

results

page

of 62

1

Cite

Cite

Copy

Share

Share

Copy

Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome.

Joong Yeup LEE ; Jin Cheol TAE ; Chung Hyon KIM ; Doyeong HWANG ; Ki Chul KIM ; Chang Suk SUH ; Seok Hyun KIM

Clinical and Experimental Reproductive Medicine.2017;44(3):146-151. doi:10.5653/cerm.2017.44.3.146

OBJECTIVE: To identify differences in the expression of the genes for peroxisome proliferator-activated receptor (PPAR)-γ, cyclooxygenase (COX)-2, and the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α in granulosa cells (GCs) from polycystic ovary syndrome (PCOS) patients and controls undergoing controlled ovarian stimulation. METHODS: Nine patients with PCOS and six controls were enrolled in this study. On the day of oocyte retrieval, GCs were collected from pooled follicular fluid. Total mRNA was extracted from GCs. Reverse transcription was performed and gene expression levels were quantified by realtime quantitative polymerase chain reaction. RESULTS: There were no significant differences in age, body mass index, and total gonadotropin dose, except for the ratio of luteinizing hormone to follicle-stimulating hormone between the PCOS and control groups. PPAR-γ and COX-2 mRNA was significantly downregulated in the GCs of PCOS women compared with controls (p=0.034 and p=0.018, respectively), but the expression of IL-6 and TNF-α mRNA did not show significant differences. No significant correlation was detected between the expression of these mRNA sequences and clinical characteristics, including the number of retrieved oocytes, oocyte maturity, cleavage, or the good embryo rate. Positive correlations were found among the PPAR-γ, COX-2, IL-6, and TNF-α mRNA levels. CONCLUSION: Our data may provide novel clues regarding ovarian GC dysfunction in PCOS, and indirectly provide evidence that the effect of PPAR-γ agonists in PCOS might result from alterations in the ovarian follicular environment. Further studies with a larger sample size are required to confirm these proposals.
Body Mass Index ; Cyclooxygenase 2* ; Cytokines* ; Embryonic Structures ; Female ; Follicle Stimulating Hormone ; Follicular Fluid ; Gene Expression ; Gonadotropins ; Granulosa Cells* ; Humans ; Interleukin-6 ; Interleukins ; Luteinizing Hormone ; Oocyte Retrieval ; Oocytes ; Ovulation Induction ; Peroxisomes* ; Polycystic Ovary Syndrome* ; Polymerase Chain Reaction ; PPAR gamma ; Prostaglandin-Endoperoxide Synthases ; Reverse Transcription ; RNA, Messenger ; Sample Size ; Tumor Necrosis Factor-alpha

Body Mass Index ; Cyclooxygenase 2* ; Cytokines* ; Embryonic Structures ; Female ; Follicle Stimulating Hormone ; Follicular Fluid ; Gene Expression ; Gonadotropins ; Granulosa Cells* ; Humans ; Interleukin-6 ; Interleukins ; Luteinizing Hormone ; Oocyte Retrieval ; Oocytes ; Ovulation Induction ; Peroxisomes* ; Polycystic Ovary Syndrome* ; Polymerase Chain Reaction ; PPAR gamma ; Prostaglandin-Endoperoxide Synthases ; Reverse Transcription ; RNA, Messenger ; Sample Size ; Tumor Necrosis Factor-alpha

2

Cite

Cite

Copy

Share

Share

Copy

Efficacy of embryo transfer on day 2 versus day 3 according to maternal age in patients with normal ovarian response.

Jung Woo LEE ; Jeong Ho CHA ; Sun Hee SHIN ; Yun Jeong KIM ; Seul Ki LEE ; Choon keun PARK ; Kyung Ah PAK ; Ji Sung YOON ; Seo Young PARK

Clinical and Experimental Reproductive Medicine.2017;44(3):141-145. doi:10.5653/cerm.2017.44.3.141

OBJECTIVE: Delaying embryo transfer (ET) enables us to select among the embryos available for transfer and is associated with positive effects on implantation and pregnancy outcomes. However, the optimal day for ET of human cleavage-stage embryos remains controversial. METHODS: A retrospective study of 3,124 in vitro fertilization/intracytoplasmic sperm injection cycles (2,440 patients) was conducted. We compared the effects of day 2 and 3 ET on rates of implantation and pregnancy outcomes between young maternal age (YMA; <38 years old, n=2,295) and old maternal age (OMA; ≥38 years old, n=829) patient groups. RESULTS: The YMA and OMA groups did not differ in terms of patient characteristics except for the proportion of unexplained factor infertility, which was significantly greater in the OMA group, and the proportion of arrested embryos, which was significantly greater in the YMA group. However, the biochemical pregnancy, clinical pregnancy, ongoing pregnancy, abortion, and implantation rates per cycle were not significantly different between day 2 and 3 ET in the YMA group or the OMA group. CONCLUSION: We suggest that offering patients the opportunity to decide which day would be suitable for ET could be part of a patient-friendly protocol that takes into consideration an infertile woman's circumstances and work schedule by allowing ET to be performed on day 2 instead of the traditional transfer on day 3.
Appointments and Schedules ; Embryo Transfer* ; Embryonic Structures* ; Female ; Humans ; In Vitro Techniques ; Infertility ; Maternal Age* ; Pregnancy ; Pregnancy Outcome ; Retrospective Studies ; Spermatozoa

Appointments and Schedules ; Embryo Transfer* ; Embryonic Structures* ; Female ; Humans ; In Vitro Techniques ; Infertility ; Maternal Age* ; Pregnancy ; Pregnancy Outcome ; Retrospective Studies ; Spermatozoa

3

Cite

Cite

Copy

Share

Share

Copy

ICSI significantly improved the pregnancy rate of patients with a high sperm DNA fragmentation index.

Hee Jun CHI ; Seok Gi KIM ; Youn Young KIM ; Ji Young PARK ; Chang Seok YOO ; Il Hae PARK ; Hong Gil SUN ; Jae Won KIM ; Kyeong Ho LEE ; Hum Dai PARK

Clinical and Experimental Reproductive Medicine.2017;44(3):132-140. doi:10.5653/cerm.2017.44.3.132

OBJECTIVE: Correlations between semen parameters and sperm DNA fragmentation index (DFI) were investigated to identify characteristics of sperm without DNA damage that could be used in selecting sperm for intracytoplasmic sperm injection (ICSI). Pregnancy outcomes were compared to determine whether in vitro fertilization (IVF) or ICSI is a better choice for patients who have sperm with a high-DFI. METHODS: Semen analysis was carried out in 388 patients who visited our IVF center for the first time to investigate correlations between sperm DFI and semen parameters. In addition, 1,102 IVF cycles in 867 patients were carried out in the present study; 921 cycles in the low-DFI group (DFI <30%) and 181 cycles in the high-DFI group (DFI ≥30%). Both the low- and high-DFI groups were subdivided into IVF and ICSI cycle groups. RESULTS: Sperm DFI showed significant inverse correlations with sperm motility (r=−0.435, p<0.001) and morphology (r=−0.153, p<0.05). Sperm DFI also showed significant correlations with rapid motility (r=−0.436, p<0.001), and the kinetic parameters of average-path velocity (r=−0.403) and linearity (r=−0.412). Although there was no significant difference in the pregnancy rates between IVF (48.6%) and ICSI (44.8%) in the low-DFI group, the pregnancy rate of ICSI cycles (44.8%, p<0.05) was significantly higher than IVF cycles (25.0%) in the high-DFI group. No significant difference was observed in the abortion rates between the low-DFI (52 of 921, 5.6%) and high-DFI groups (7 of 181, 3.8%). CONCLUSION: ICSI is a better choice than IVF for improving the pregnancy outcomes of patients who have sperm with a high DFI.
Abortion, Induced ; DNA Damage ; DNA Fragmentation* ; DNA* ; Female ; Fertilization in Vitro ; Humans ; Pregnancy Outcome ; Pregnancy Rate* ; Pregnancy* ; Semen ; Semen Analysis ; Sperm Injections, Intracytoplasmic* ; Sperm Motility ; Spermatozoa*

Abortion, Induced ; DNA Damage ; DNA Fragmentation* ; DNA* ; Female ; Fertilization in Vitro ; Humans ; Pregnancy Outcome ; Pregnancy Rate* ; Pregnancy* ; Semen ; Semen Analysis ; Sperm Injections, Intracytoplasmic* ; Sperm Motility ; Spermatozoa*

4

Cite

Cite

Copy

Share

Share

Copy

A case of 17 alpha-hydroxylase deficiency.

Sung Mee KIM ; Jeong Ho RHEE

Clinical and Experimental Reproductive Medicine.2015;42(2):72-76. doi:10.5653/cerm.2015.42.2.72

17alpha-hydroxylase and 17,20-lyase are enzymes encoded by the CYP17A1 gene and are required for the synthesis of sex steroids and cortisol. In 17alpha-hydroxylase deficiency, there are low blood levels of estrogens, androgens, and cortisol, and resultant compensatory increases in adrenocorticotrophic hormone that stimulate the production of 11-deoxycorticosterone and corticosterone. In turn, the excessive levels of mineralocorticoids lead to volume expansion and hypertension. Females with 17alpha-hydroxylase deficiency are characterized by primary amenorrhea and delayed puberty, with accompanying hypertension. Affected males usually have female external genitalia, a blind vagina, and intra-abdominal testes. The treatment of this disorder is centered on glucocorticoid and sex steroid replacement. In patients with 17alpha-hydroxylase deficiency who are being raised as females, estrogen should be supplemented, while genetically female patients with a uterus should also receive progesterone supplementation. Here, we report a case of a 21-year-old female with 17alpha-hydroxylase deficiency who had received inadequate treatment for a prolonged period of time. We also include a brief review of the recent literature on this disorder.
Adrenocorticotropic Hormone ; Amenorrhea ; Androgens ; Corticosterone ; Estrogens ; Female ; Genitalia ; Humans ; Hydrocortisone ; Hypertension ; Male ; Mineralocorticoids ; Progesterone ; Puberty, Delayed ; Steroid 17-alpha-Hydroxylase* ; Steroids ; Testis ; Uterus ; Vagina ; Young Adult

Adrenocorticotropic Hormone ; Amenorrhea ; Androgens ; Corticosterone ; Estrogens ; Female ; Genitalia ; Humans ; Hydrocortisone ; Hypertension ; Male ; Mineralocorticoids ; Progesterone ; Puberty, Delayed ; Steroid 17-alpha-Hydroxylase* ; Steroids ; Testis ; Uterus ; Vagina ; Young Adult

5

Cite

Cite

Copy

Share

Share

Copy

A role for endocannabinoids in acute stress-induced suppression of the hypothalamic-pituitary-gonadal axis in male rats.

Maryam KARAMIKHEIRABAD ; Gila BEHZADI ; Mahdieh FAGHIHI ; Reza RAOOFIAN ; Shahram EJTEMAEI MEHR ; Wieteke Ameliek ZUURE ; Hamid Reza SADEGHIPOUR

Clinical and Experimental Reproductive Medicine.2013;40(4):155-162. doi:10.5653/cerm.2013.40.4.155

OBJECTIVE: Stress is known to be an inhibitor of the reproductive hypothalamic-pituitary-gonadal (HPG) axis. However, the neural and molecular connections between stress and reproduction are not yet understood. It is well established that in both humans and rodents, kisspeptin (encoded by the kiss1 gene) is a strong stimulator of the HPG axis. In the present study we hypothesized that endocannabinoids, an important neuromodulatory system in the brain, can act on the HPG axis at the level of kiss1 expression to inhibit reproductive function under stress. METHODS: Adult male Wistar rats were unilaterally implanted with an intracerebroventricular cannula. Afterwards, the animals were exposed to immobilization stress, with or without the presence of the cannabinoid CB1 receptor antagonist AM251 (1 microg/rat). Blood samples were collected through a retro-orbital plexus puncture before and after stress. Five hours after the stress, brain tissue was collected for reverse transcriptase-quantitative polymerase chain reaction measurements of kiss1 mRNA. RESULTS: Immobilization stress (1 hour) resulted in a decrease in the serum luteinizing hormone concentration. Additionally, kiss1 gene expression was decreased in key hypothalamic nuclei that regulate gonadotrophin secretion, the medial preoptic area (mPOA), and to some extent the arcuate nucleus (ARC). A single central administration of AM251 was effective in blocking these inhibitory responses. CONCLUSION: These findings suggest that endocannabinoids mediate, at least in part, immobilization stress-induced inhibition of the reproductive system. Our data suggest that the connection between immobilization stress and the HPG axis is kiss1 expression in the mPOA rather than the ARC.
Adult ; Animals ; Arcuate Nucleus ; Axis, Cervical Vertebra* ; Brain ; Cannabinoids ; Catheters ; Endocannabinoids* ; Gene Expression ; Humans ; Immobilization ; Kisspeptins ; Luteinizing Hormone ; Male* ; Polymerase Chain Reaction ; Preoptic Area ; Punctures ; Rats* ; Rats, Wistar ; Receptor, Cannabinoid, CB1 ; Reproduction ; RNA, Messenger ; Rodentia

Adult ; Animals ; Arcuate Nucleus ; Axis, Cervical Vertebra* ; Brain ; Cannabinoids ; Catheters ; Endocannabinoids* ; Gene Expression ; Humans ; Immobilization ; Kisspeptins ; Luteinizing Hormone ; Male* ; Polymerase Chain Reaction ; Preoptic Area ; Punctures ; Rats* ; Rats, Wistar ; Receptor, Cannabinoid, CB1 ; Reproduction ; RNA, Messenger ; Rodentia

6

Cite

Cite

Copy

Share

Share

Copy

Closed vitrification of mouse oocytes using the CryoLogic vitrification method: A modification that improves developmental competence.

Jun Woo JO ; Byung Chul JEE ; Chang Suk SUH ; Seok Hyun KIM

Clinical and Experimental Reproductive Medicine.2013;40(4):148-154. doi:10.5653/cerm.2013.40.4.148

OBJECTIVE: To compare the mouse oocyte vitrification outcomes of the CryoLogic vitrification method (CVM) and the conventional open method using a Cryotop. Two CVM methods (original CVM and modified CVM) were tested. METHODS: Mature oocytes obtained from female BDF-1 mice were vitrified by two-step exposure to equilibrium and vitrification solutions. Three vitrification protocols were tested on three groups: the CVM-kit, modified CVM, and Cryotop groups. After exposure to the two solutions, the oocytes were vitrified. After warming, the oocytes were fertilized in vitro, and the embryo development was assessed. Blastomeres positive for caspase were counted using an in situ assay kit. The spindle morphology and chromosome configurations of warmed vitrified oocytes were also assessed. RESULTS: The modified CVM and Cryotop groups showed similar developmental capacities, and similar proportions of cells with intact spindles and chromosome configurations. The modified CVM protocol was superior to the original CVM protocol for developmental competence and intact spindle preservation. However, the CVM group showed a relatively higher number of apoptotic cells in blastocysts. CONCLUSION: Closed vitrification using the modified CVM protocol may be used as an alternative to the conventional open method, but strategies to decrease apoptosis in the blastomere need to be investigated.
Animals ; Apoptosis ; Blastocyst ; Blastomeres ; Embryonic Development ; Female ; Humans ; Mental Competency* ; Methods ; Mice* ; Oocytes* ; Pregnancy ; Vitrification*

Animals ; Apoptosis ; Blastocyst ; Blastomeres ; Embryonic Development ; Female ; Humans ; Mental Competency* ; Methods ; Mice* ; Oocytes* ; Pregnancy ; Vitrification*

7

Cite

Cite

Copy

Share

Share

Copy

In vitro maturation: Clinical applications.

Kyung Sil LIM ; Soo Jin CHAE ; Chang Woo CHOO ; Yeon Hee KU ; Hye Jun LEE ; Chang Young HUR ; Jin Ho LIM ; Won Don LEE

Clinical and Experimental Reproductive Medicine.2013;40(4):143-147. doi:10.5653/cerm.2013.40.4.143

Oocyte in vitro maturation (IVM) is an assisted reproductive technology in which oocytes are retrieved from the antral follicles of unstimulated or minimally stimulated ovaries. IVM of human oocytes has emerged as a promising procedure. This new technology has advantages over controlled ovarian stimulation such as reduction of costs, simplicity, and elimination of ovarian hyperstimulation syndrome. By elimination or reduction of gonadotropin stimulation, IVM offers eligible infertile couples a safe and convenient form of treatment, and IVM outcomes are currently comparable in safety and efficacy to those of conventional in vitro fertilization. IVM has been applied mainly in patients with polycystic ovary syndrome or ultrasound-only polycystic ovaries, but with time, the indications for IVM have expanded to other uncommon situations such as fertility preservation, as well as to normal responders. In this review, the current clinical experiences with IVM will be described.
Family Characteristics ; Female ; Fertility Preservation ; Fertilization in Vitro ; Gonadotropins ; Humans ; In Vitro Oocyte Maturation Techniques ; Infertility ; Oocytes ; Ovarian Hyperstimulation Syndrome ; Ovary ; Ovulation Induction ; Polycystic Ovary Syndrome ; Reproductive Techniques, Assisted

Family Characteristics ; Female ; Fertility Preservation ; Fertilization in Vitro ; Gonadotropins ; Humans ; In Vitro Oocyte Maturation Techniques ; Infertility ; Oocytes ; Ovarian Hyperstimulation Syndrome ; Ovary ; Ovulation Induction ; Polycystic Ovary Syndrome ; Reproductive Techniques, Assisted

8

Cite

Cite

Copy

Share

Share

Copy

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome.

Kyu Ri HWANG ; Young Min CHOI ; Jin Ju KIM ; Soo Jin CHAE ; Kyung Eui PARK ; Hye Won JEON ; Seung Yup KU ; Seok Hyun KIM ; Jung Gu KIM ; Shin Yong MOON

Clinical and Experimental Reproductive Medicine.2013;40(2):100-105. doi:10.5653/cerm.2013.40.2.100

OBJECTIVE: The aim of this study was to investigate the effect of insulin sensitizing agents on hormonal and metabolic parameters as well as menstrual patterns in women with polycystic ovary syndrome (PCOS). METHODS: One hundred and twenty-three patients with PCOS were included. Metformin was administered to patients at 1,500 mg or 1,700 mg daily for 3 months. If the patients had no improvement of the menstrual cycle or metformin-related adverse effects developed, the patients changed medication to a daily dose of either 15 mg pioglitazone or up to 45 mg. Then resumption of a regular menstrual cycle or recovery of ovulation was evaluated. Hormonal and metabolic profiles were compared between the response and non-response group to insulin sensitizing agents. RESULTS: One hundred and five patients with PCOS were treated with metformin for 3 months. Forty-eight patients (45.7%) showed improvement of menstrual cycle regularity after 3 months of metformin use, whereas 57 patients (54.3%) had no change. The mean free testosterone measured after 3 months of treatment was significantly lower in metformin responders than in non-responders. The other parameters did not differ between the groups. Of the 23 patients who used pioglitazone for 3 to 6 months, 19 patients (82.6%) showed improvement in their menstrual cycles. CONCLUSION: Metformin treatment seems to be effective for the improvement of menstrual cyclicity irrespective of insulin resistance in women with PCOS. When metformin related adverse effect occurred, pioglitazone would be effective for aiding the resumption of the menstrual cycle.
Female ; Humans ; Insulin ; Insulin Resistance ; Menstrual Cycle ; Metabolome ; Metformin ; Ovulation ; Periodicity ; Polycystic Ovary Syndrome ; Testosterone ; Thiazolidinediones

Female ; Humans ; Insulin ; Insulin Resistance ; Menstrual Cycle ; Metabolome ; Metformin ; Ovulation ; Periodicity ; Polycystic Ovary Syndrome ; Testosterone ; Thiazolidinediones

9

Cite

Cite

Copy

Share

Share

Copy

Association between serum anti-Mullerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome.

Ju Yeong KIM ; Gwang YI ; Yeo Rang KIM ; Jae Yeon CHUNG ; Ji Hyun AHN ; You Kyoung UHM ; Byung Chul JEE ; Chang Suk SUH ; Seok Hyun KIM

Clinical and Experimental Reproductive Medicine.2013;40(2):95-99. doi:10.5653/cerm.2013.40.2.95

OBJECTIVE: To evaluate the correlation between serum levels of anti-Mullerian hormone (AMH) and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome (PCOS). METHODS: Seventy-four cycles of mild stimulation (clomiphene citrate+gonadotropin followed by timed intercourse or intrauterine insemination) performed in normoovulatory women (57 cycles) and anovulatory women with PCOS (17 cycles). Ovarian sensitivity was defined by the number of mature follicles (> or =14 mm) on triggering day per 100 IU of gonadotropin. A correlation between ovarian sensitivity and the baseline serum AMH level (absolute or multiples of the median [MoM] value for each corresponding age) was calculated. Correlation between ovarian response and serum AMH level was evaluated. RESULTS: Ovarian sensitivity to mild stimulation was positively correlated with absolute serum AMH (r=0.535, p<0.001) or AMH-MoM value (r=0.390, p=0.003) in normoovulatory women, but this correlation was not observed in anovulatory women with PCOS (r=0.105, p>0.05, r=-0.265, p>0.05, respectively). CONCLUSION: Ovarian response to mild stimulation is possibly predicted by the serum AMH level in normoovulatory women, but not in anovulatory women with PCOS.
Anti-Mullerian Hormone ; Female ; Gonadotropins ; Humans ; Ovulation Induction ; Polycystic Ovary Syndrome

Anti-Mullerian Hormone ; Female ; Gonadotropins ; Humans ; Ovulation Induction ; Polycystic Ovary Syndrome

10

Cite

Cite

Copy

Share

Share

Copy

The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles.

Min Hye CHOI ; Sun Hwa CHA ; Chan Woo PARK ; Jin Young KIM ; Kwang Moon YANG ; In Ok SONG ; Mi Kyoung KOONG ; Inn Soo KANG ; Hye Ok KIM

Clinical and Experimental Reproductive Medicine.2013;40(2):90-94. doi:10.5653/cerm.2013.40.2.90

OBJECTIVE: To evaluate the efficacy of earlier oocyte retrieval in IVF patients with a premature LH surge on hCG day. METHODS: One hundred forty IVF patients (164 cycles) with premature LH surge on hCG day were included, retrospectively. We divided them into 2 study groups: LH surge with timed ovum pick-up (OPU) 36 hours after hCG injection (group B, 129 premature cycles), and LH surge with earlier OPU within 36 hours after hCG injection (group C, 35 cycles). Control groups were tubal factor infertility without premature LH surge (group A, 143 cycles). RESULTS: The mean age (year) was statistically higher in group C than in groups A or B (38.2+/-5.4 vs. 36.2+/-4.2 vs. 36.8+/-4.9, respectively; p=0.012). The serum LH levels (mIU/mL) on hCG day were significantly higher in group B and C than in group A (22.7+/-14.9 vs. 30.3+/-15.9 vs. 3.2+/-2.9, respectively; p>0.001). Among groups A, B, and C, 4.9%, 31.7%, and 51.4% of the cycles, respectively, had no oocytes, and the overall rates of cycle cancellation (OPU cancellation, no oocyte, or no embryos transferrable) were 15.4%, 65.9%, and 74.3%, respectively. The fertilization rate (%) was significantly higher in group B than in group C (73.2+/-38.9 vs. 47.8+/-42.9, p=0.024). The clinical pregnancy rate was significantly higher in group C than in groups A and B (44.4% vs. 27.3% vs. 9.1%, respectively, p=0.021). However, the miscarriage rate was also higher in group C than in group B (22% vs. 0%, respectively, p=0.026). CONCLUSION: Earlier OPU may not be effective in reducing the risk of cycle cancellation in patients with premature LH surge on hCG day. A larger scale study will be required to reveal the effectiveness of earlier ovum retrieval with premature LH surge.
Abortion, Spontaneous ; Embryonic Structures ; Female ; Fertilization ; Fertilization in Vitro ; Humans ; Infertility ; Lutein ; Luteinizing Hormone ; Oocyte Retrieval ; Oocytes ; Ovum ; Pregnancy ; Pregnancy Rate ; Retrospective Studies

Abortion, Spontaneous ; Embryonic Structures ; Female ; Fertilization ; Fertilization in Vitro ; Humans ; Infertility ; Lutein ; Luteinizing Hormone ; Oocyte Retrieval ; Oocytes ; Ovum ; Pregnancy ; Pregnancy Rate ; Retrospective Studies

Country

Republic of Korea

Publisher

The Korean Society for Reproductive Medicine

ElectronicLinks

http://ecerm.org/

Editor-in-chief

Inn Soo Kang

E-mail

ikang@cha.ac.kr

Abbreviation

Clin Exp Reprod Med

Vernacular Journal Title

대한생식의학회지

ISSN

2233-8233

EISSN

2233-8241

Year Approved

2007

Current Indexing Status

Currently Indexed

Start Year

Description

Clinical and Experimental Reproductive Medicine (CERM) is an international peer-reviewed journal for the gynecologists, reproductive endocrinologists, urologists and basic scientists providing a recent advancement in our understanding of human and animal reproduction. CERM is an official journal of Pacific Society for Reproductive Medicine, the Korean Society for Reproductive Medicine and Korean Society for Assisted Reproduction.

Previous Title

Clinical and Experimental Reproductive Medicine
Korean Journal of Fertility and Sterility

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.